Procurement of blood collection kits for the UK Biobank study of seroprevalence of COVID-19

UK BIOBANK LIMITEDcontractContracts FinderRef MT219630SME suitablecomplete

Estimated value

£474k

Awarded value

£474k

Awarded 22 Apr 2020

Suppliers

1

Lots

1

1 awarded

Published

25 May 2020

Deadline 01 Jan 2020

Description

UK Biobank ("UKB") is conducting a study of seroprevalence of COVID 19 in the population of up to 20,000 of its participants and their adult children and grandchildren (the "Study"). The Study (which is funded for an initial period of 6 months by the Department of Health and Social Care) aims to collect blood samples from study participants each month for an initial period of six months and measure these samples to assess the extent of previous infection with the SARS CoV 2 coronavirus (by measuring blood antibodies) in different locations and age groups across the UK. In order to enable the Study, UKB needed a supplier to provide testing kits which could be mailed to study participants and safely returned to UKB's laboratory in Cheadle before testing. There was an urgent need to secure supply of kits (which are globally in high demand) to enable the study to go ahead without delay. Med DX were identified as a supplier who were able to provide these kits to enable the Study to commence within the required urgent timeframe.

Scope

Reference
MT219630
Total value
£474,000 excluding VAT
Commercial tool
Standalone contract
Contract dates
22 Apr 2020 to 22 Oct 2020
CPV classifications
33141000
Particular suitability
Small and medium-sized enterprises (SME)

Submission & procedure

Submission deadline
01 Jan 2020, 12:00 am

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£474k

Award date

22 Apr 2020

Contract start

22 Apr 2020

Contract end

22 Oct 2020

Awarded to